FierceBiotech  Aug 4  Comment 
Amarin slips after adding second interim efficacy trial to PhIII CV trial ntaylor Thu, 08/04/2016 - 11:31
SeekingAlpha  Aug 4  Comment 
Benzinga  Aug 1  Comment 
  First Majestic Silver Corp (NYSE: AG) shares gained 3.23 percent to touch a new 52-week high of $17. First Majestic Silver is scheduled to report its Q2 unaudited financial results on Wednesday, August 10, 2016. MeetMe Inc (NASDAQ:...
Motley Fool  Jun 27  Comment 
Can Amarin continue to swim upstream?
Motley Fool  May 31  Comment 
Even though the stock market was mixed, these stocks gained. Find out why.
Motley Fool  May 30  Comment 
Agenus and Amarin's share prices could soar over the next year. Are these two speculative biotechs worth the risk?



This is a test No its not

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki